BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 22086887)

  • 1. Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidelines for adults.
    Hendriksz T; Malouf P; Foy JE;
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S10-2. PubMed ID: 22086887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines in dermatological diseases.
    Magel GD; Mendoza N; Digiorgio CM; Haitz KA; Lapolla WJ; Tyring SK
    G Ital Dermatol Venereol; 2011 Jun; 146(3):225-33. PubMed ID: 21566552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult immunizations: update on recommendations.
    Pham H; Geraci SA; Burton MJ;
    Am J Med; 2011 Aug; 124(8):698-701. PubMed ID: 21658665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of herpes zoster among varicella-vaccinated children, by number of vaccine doses and simultaneous administration of measles, mumps, and rubella vaccine.
    Weinmann S; Irving SA; Koppolu P; Naleway AL; Belongia EA; Hambidge SJ; Jackson ML; Klein NP; Lewin B; Liles E; Marin M; Smith N; Weintraub E; Chun C
    Vaccine; 2020 Aug; 38(37):5880-5884. PubMed ID: 32444193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR; Black S; Kuter BJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against chickenpox, shingles and rotavirus-infection].
    Hartwig NG; Rümke HC; Visser HK
    Ned Tijdschr Geneeskd; 2009; 153():A913. PubMed ID: 19900343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunization against varicella and zoster].
    Floret D
    Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
    Blatter MM; Klein NP; Shepard JS; Leonardi M; Shapiro S; Schear M; Mufson MA; Martin JM; Varman M; Grogg S; London A; Cambron P; Douha M; Nicholson O; da Costa C; Innis BL
    Pediatr Infect Dis J; 2012 Aug; 31(8):e133-40. PubMed ID: 22622699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chickenpox: sufficient reasons for the introduction of vaccination].
    Rümke H; de Groot R
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2630-2. PubMed ID: 17205937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
    Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F
    AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measles, mumps, rubella and varicella: antibody titration and vaccinations in a large hospital].
    Cologni L; Belotti L; Bacis M; Moioli F; Goglio A; Mosconi G
    G Ital Med Lav Ergon; 2012; 34(3 Suppl):272-4. PubMed ID: 23405639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.
    Vesikari T; Becker T; Gajdos V; Fiquet A; Thomas S; Richard P; Baudin M
    Vaccine; 2012 Apr; 30(20):3082-9. PubMed ID: 22406278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new combination vaccine for measles, mumps, rubella and varicella.
    Zareba G
    Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella.
    Ramet J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S49-55. PubMed ID: 18162247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined vaccine against measles, mumps, rubella and varicella and recommendations for varicella immunization in Italy?].
    Papa R; Spinelli R; Zaratti L; Franco E
    Ig Sanita Pubbl; 2007; 63(6):715-22. PubMed ID: 18216886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live (vaccines) from New York.
    Forlenza CJ; Small TN
    Bone Marrow Transplant; 2013 Jun; 48(6):749-54. PubMed ID: 22890288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.